Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-29

Clinical Trial Update: Effect of Donepezil on Cognition in Parkinson's Disease With Mild Cognitive Impairment (PD-MCI) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study assessing whether donepezil improves cognitive function in Parkinson's disease patients with mild cognitive i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil (donepezil)

Snippet

Sponsor: Yonsei University | Conditions: Parkinson's Disease | Phase 2 | Status: UNKNOWN